News

Servier and Galapagos entered into the alliance in July 2010 to build on novel OA drug targets discovered by Galapagos through its proprietary platform. Galapagos is responsible for

DSM Biologics provides and develops technologies relevant for optimized mammalian cell culture processes. The contract covers the process development and cGMP manufacturing by DSM of their lead product

Daniel had blamed the company for getting breast cancer after taking its Prempro menopause drug, bloomberg.com reported. A Pennsylvania appeals court overturned a ruling that Pfizer’s Wyeth unit

SironRX is a spinoff of the privately-held biotechnology company Juventas Therapeutics which licensed the drug’s intellectual property from Cleveland Clinic in 2007. SironRX’s lead drug JVS-100 contains an

The BLISS-52 study, one of two pivotal Phase 3 trials, was designed to evaluate the efficacy and safety of belimumab plus standard of care, versus placebo plus standard

The study is in addition to the companies’ joint Phase 3 RENAISSANCE Program for TC-5214 as an adjunctive treatment for MDD. The RENAISSANCE Program is designed to support

The study showed that women who were treated with a combination of Avastin and chemotherapy (carboplatin and gemcitabine), followed by continued use of Avastin alone until disease progression,

Viibryd is a novel drug for the treatment of adults with major depressive disorder (MDD). ScinoPharm president and CEO Jo Shen said beginning from process research through timely

SMSH is the parent company of American Health, a provider of Medicare Advantage services to over 40,000 dual and non-dual eligible members in Puerto Rico. Triple-S Management president